The PNPLA3 variant I148M reveals protective effects toward hepatocellular carcinoma in mice via restoration of omega-3 polyunsaturated fats
Open Access
- 10 June 2022
- journal article
- research article
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 108, 109081
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosisJournal of Clinical Investigation, 2012
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- The PNPLA3 rs738409 148M/M Genotype Is a Risk Factor for Liver Cancer in Alcoholic Cirrhosis but Shows No or Weak Association in Hepatitis C CirrhosisPLOS ONE, 2011
- Expression and Characterization of a PNPLA3 Protein Isoform (I148M) Associated with Nonalcoholic Fatty Liver DiseaseJournal of Biological Chemistry, 2011
- Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndromeJournal of Lipid Research, 2011
- Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasiansHepatology, 2010
- Patatin-Like Phospholipase Domain-Containing 3/Adiponutrin Deficiency in Mice Is Not Associated with Fatty Liver Disease†,‡Hepatology, 2010
- The changing pattern of epidemiology in hepatocellular carcinomaDigestive and Liver Disease, 2010
- Protection from hepatic lipid accumulation and inflammation by genetic ablation of 5-lipoxygenaseProstaglandins & Other Lipid Mediators, 2010
- A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride HydrolysisJournal of Biological Chemistry, 2010